LONDON, Dec. 30, 2015 /PRNewswire/ -- Singapore Contract Research Organization Market : Singapore will Remain in the Global Spotlight as the Strategic Hub of the CRO Market in APAC.
This market insight presents an overview and analysis of the Singaporean CRO market. It provides revenue forecasts for the CRO market by phase and therapeutic type. The research study discusses the major issues and challenges, unmet needs, and emerging trends in the market. The study covers the complete life cycle of the CRO industry, from preclinical trials to post-marketing surveillance. It provides detailed information on support services, such as central laboratory services, bio-analytics, and data management. The market insight also analyses Market Engineering measurements, and R&D trends.
Clinical Development Spending
In 2014, the Singaporean contract research organization market generated $ million in revenue. The market is expected to grow at a CAGR of %, reaching $ million in 2019.
Clinical Development — Main Trends
-Singapore is currently focused on biomedical science and research, and in line with this, the government has committed $ billion between 2011 to 2015 to continue its support for this segment.
- With more development in R&D capabilities, the number of clinical trials are expected to increase with investment from multinational companies.
MNC and Local Pharmaceutical Companies
-The CRO industry in Singapore consists of to CRO and pharmaceutical companies that manage regional clinical trial programs in the country.
- The market is dominated by MNCs, such as Quintiles, PPD, Covance and Parexel, which are capitalizing on government backing, rigorous regulatory regime, sophisticated transportation and communication infrastructure, and skilled workforce available in Singapore.
Download the full report: https://www.reportbuyer.com/product/3186595/
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
For more information:
Research Advisor at Reportbuyer.com
Tel: +44 208 816 85 48